-+ 0.00%
-+ 0.00%
-+ 0.00%

Mizuho Maintains Outperform on Verastem, Lowers Price Target to $14

Benzinga·05/14/2026 12:58:25
Listen to the news
Mizuho analyst Graig Suvannavejh maintains Verastem (NASDAQ:VSTM) with a Outperform and lowers the price target from $16 to $14.